Application of Chitosan-Based Biomaterials for Blood Vessel Regeneration

Vascular diseases are the leading cause of morbidity and mortality in the western world. Autologous vessels remain the standard for coronary grafting and peripheral bypass surgery; however, their availability in patients can be limited. Therapeutic angiogenesis using growth factors, genes, or progenitor cells has been given considerable scientific attention over the last decade, but has not yet provided a definitive clinical benefit. Biomaterials could be developed to protect protein, DNA and cells against hostile conditions. Chitosan, a natural polymer of glucosamine and N-acetyl glucosamine, has been widely studied in tissue engineering due to its biocompatibility, biodegradability, and muco-adhesive and antimicrobial properties. Notably, the application of chitosan has been gaining attention in the vascular field due to its structural similarity to glycosaminoglycans, which are components of a tissue's extracellular matrix. In this review, chitosan-based materials, and their use in tissue engineered blood vessels, and as protein, gene and cell vectors for angiogenic therapy are discussed.

[1]  Frédéric Couet,et al.  Macromolecular biomaterials for scaffold-based vascular tissue engineering. , 2007, Macromolecular bioscience.

[2]  J. Loewenthal,et al.  Small arterial reconstruction using modified cadaveric saphenous veins. , 1977, American journal of surgery.

[3]  Hou Chunlin,et al.  Antibiotic loaded chitosan bar. An in vitro, in vivo study of a possible treatment for osteomyelitis. , 1999, Clinical orthopaedics and related research.

[4]  R. Mumper,et al.  Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[5]  A. Blakemore,et al.  THE USE OF TUBES CONSTRUCTED FROM VINYON “N” CLOTH IN BRIDGING ARTERIAL DEFECTS—EXPERIMENTAL AND CLINICAL , 1954, Annals of surgery.

[6]  E. Khor,et al.  Novel fabrication of open-pore chitin matrixes. , 2000, Biomacromolecules.

[7]  Zheng Qu,et al.  Polymeric Materials for Tissue Engineering of Arterial Substitutes , 2009, Vascular.

[8]  C. Powers,et al.  Fibroblast growth factors, their receptors and signaling. , 2000, Endocrine-related cancer.

[9]  M. Al-mallah,et al.  Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. , 2007, Archives of internal medicine.

[10]  K. Anseth,et al.  The effects of cell-matrix interactions on encapsulated beta-cell function within hydrogels functionalized with matrix-derived adhesive peptides. , 2007, Biomaterials.

[11]  E. Wood,et al.  Effect of Chitosan on Epithelial Cell Tight Junctions , 2004, Pharmaceutical Research.

[12]  M. Ishihara,et al.  Photocrosslinkable chitosan as a biological adhesive. , 2000, Journal of biomedical materials research.

[13]  K. Kent,et al.  What is the proper role of polytetrafluoroethylene grafts in infrainguinal reconstruction? , 1989, Journal of vascular surgery.

[14]  C. Dass,et al.  Injectable chitosan hydrogels for localised cancer therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Joel Price,et al.  Tissue-Engineered Injectable Collagen-Based Matrices for Improved Cell Delivery and Vascularization of Ischemic Tissue Using CD133+ Progenitors Expanded From the Peripheral Blood , 2006, Circulation.

[16]  In-Yong Kim,et al.  Chitosan and its derivatives for tissue engineering applications. , 2008, Biotechnology advances.

[17]  Y. Tabata,et al.  Controlled release systems of angiogenic growth factors for cardiovascular diseases , 2007, Expert opinion on drug delivery.

[18]  L. Ambrosio,et al.  Chitosan-mediated stimulation of macrophage function. , 1994, Biomaterials.

[19]  A. Lendlein,et al.  Layer-by-layer deposition of polyelectrolytes--a versatile tool for the in vivo repair of blood vessels. , 2004, Angewandte Chemie.

[20]  A. Quyyumi,et al.  Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. , 2000, The American journal of cardiology.

[21]  J L West,et al.  Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering. , 2001, Biomaterials.

[22]  H. Kong,et al.  Hydrogels used for cell-based drug delivery. , 2008, Journal of biomedical materials research. Part A.

[23]  J. Suh,et al.  Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. , 2000, Biomaterials.

[24]  Masanori Fujita,et al.  Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. , 2003, Journal of biomedical materials research. Part A.

[25]  S. Madihally,et al.  Vascular cell responses to polysaccharide materials: in vitro and in vivo evaluations. , 2000, Biomaterials.

[26]  Krishnendu Roy,et al.  Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.

[27]  P. Campochiaro.  Molecular targets for retinal vascular diseases , 2007, Journal of cellular physiology.

[28]  Richard T. Lee,et al.  Stem-cell therapy for cardiac disease , 2008, Nature.

[29]  K. Alitalo,et al.  Gene transfer as a tool to induce therapeutic vascular growth , 2003, Nature Medicine.

[30]  C M Bloor,et al.  Coronary collateral development in swine after coronary artery occlusion. , 1992, Circulation research.

[31]  E. Wellnhofer,et al.  Coronary Angioplasty, Bypass Surgery, and Retransplantation in Cardiac Transplant Patients with Graft Coronary Disease , 1998, The Thoracic and cardiovascular surgeon.

[32]  D J Mooney,et al.  Alginate hydrogels as synthetic extracellular matrix materials. , 1999, Biomaterials.

[33]  Y. Uchida,et al.  Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. , 1992, Science.

[34]  H. Greisler.  Interactions at the blood/material interface , 1990, Annals of vascular surgery.

[35]  I. Gouda,et al.  Heparin-chitosan complexes stimulate wound healing in human skin. , 1997, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[36]  R. Muzzarelli,et al.  Biological activity of chitosan: ultrastructural study. , 1988, Biomaterials.

[37]  M. Morimoto,et al.  Effects of chitin/chitosan and their oligomers/monomers on migrations of fibroblasts and vascular endothelium. , 2002, Biomaterials.

[38]  Y. Okamoto,et al.  Migration of canine neutrophils to chitin and chitosan. , 1994, The Journal of veterinary medical science.

[39]  J. Verweij,et al.  The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; a review. , 2006, European journal of cancer.

[40]  E Bell,et al.  A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.

[41]  N. Vrana,et al.  Characterization of Poly(vinyl alcohol)/Chitosan Hydrogels as Vascular Tissue Engineering Scaffolds , 2008 .

[42]  W. Schaper,et al.  Vascular remodeling and altered protein expression during growth of coronary collateral arteries. , 1998, Journal of molecular and cellular cardiology.

[43]  M. Tabrizian,et al.  Nanocoatings onto arteries via layer-by-layer deposition: toward the in vivo repair of damaged blood vessels. , 2003, Journal of the American Chemical Society.

[44]  Longan Shang,et al.  Initial investigation of novel human-like collagen/chitosan scaffold for vascular tissue engineering. , 2009, Journal of biomedical materials research. Part A.

[45]  Masanori Fujita,et al.  Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. , 2004, Biomaterials.

[46]  Willard C. Johnson,et al.  A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. , 2000, Journal of vascular surgery.

[47]  Y. Okamoto,et al.  Chitin and chitosan induce migration of bovine polymorphonuclear cells. , 1994, The Journal of veterinary medical science.

[48]  G L'Italien,et al.  Effect of compliance mismatch on vascular graft patency. , 1987, Journal of vascular surgery.

[49]  P. Sawyer,et al.  Tanned Collagen Arterial Prosthesis of Bovine Carotid Origin in Man: Preliminary Studies of Enzyme‐treated Heterografts , 1966, Annals of surgery.

[50]  Tong Hao,et al.  Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. , 2009, Tissue engineering. Part A.

[51]  Alexander M Seifalian,et al.  Current status of prosthetic bypass grafts: a review. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[52]  T. Maehara,et al.  Chitosan hydrogel as a drug delivery carrier to control angiogenesis , 2006, Journal of Artificial Organs.

[53]  Axel Haverich,et al.  Tissue engineering of small diameter vascular grafts. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[54]  A. Haverich,et al.  Polymerized Degradable Hyaluronan – a Platform for Stent Coating with Inherent Inhibitory Effects on Neointimal Formation in a Porcine Coronary Model , 2002 .

[55]  Aijun Wang,et al.  A sandwich tubular scaffold derived from chitosan for blood vessel tissue engineering. , 2006, Journal of biomedical materials research. Part A.

[56]  S. Hirano,et al.  N-acetylation in chitosan and the rate of its enzymic hydrolysis. , 1989, Biomaterials.

[57]  Elazer R Edelman,et al.  Arterial Ultrastructure Influences Transport of Locally Delivered Drugs , 2002, Circulation research.

[58]  Mohammed Berrada,et al.  A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[59]  F. Zhao,et al.  Regulation of vascular smooth muscle cells on poly(ethylene terephthalate) film by O-carboxymethylchitosan surface immobilization. , 2008, Journal of biomedical materials research. Part A.

[60]  Y. Okamoto,et al.  Chitin and chitosan stimulate canine polymorphonuclear cells to release leukotriene B4 and prostaglandin E2. , 1998, Journal of biomedical materials research.

[61]  K. Mislick,et al.  Evidence for the role of proteoglycans in cation-mediated gene transfer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[62]  K Walsh,et al.  Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.

[63]  F. Sellke,et al.  Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[64]  R. Muzzarelli,et al.  Reconstruction of parodontal tissue with chitosan. , 1989, Biomaterials.

[65]  M S Conte,et al.  The ideal small arterial substitute: a search for the Holy Grail? , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[66]  S. Madihally,et al.  Porous chitosan scaffolds for tissue engineering. , 1999, Biomaterials.